Clinical Trials Logo

Memory Disorders clinical trials

View clinical trials related to Memory Disorders.

Filter by:

NCT ID: NCT05737498 Not yet recruiting - Clinical trials for Working Memory Deficits

Transcranial Direct Current Stimulation (tDCS) on Working Memory in College Going Students

Start date: February 28, 2023
Phase: N/A
Study type: Interventional

Working memory deficiencies, might make it difficult for students to recall instructions, complete complex activities, and grasp and follow directions solving a math problem or writing a sentence. The functions of working memory are critical for effective human activity. Transcranial direct current stimulation (tDCS) has grown in popularity and academic interest in recent years as a way to improve cognitive abilities. so there is need to determine the effect of tdcs on working memory in college going students.

NCT ID: NCT05710549 Recruiting - Alzheimer Disease Clinical Trials

Understanding Brain Mechanisms Involved in Autobiographical Memory

Start date: April 25, 2022
Phase: N/A
Study type: Interventional

The overall objective of this project is to characterize the spatiotemporal dynamics of brain oscillations underpinning autobiographical memory (ABM) and the modulation of the memory network using non-invasive brain stimulation.

NCT ID: NCT05709210 Recruiting - Alzheimer Disease Clinical Trials

Pilot Study on the Feasibility of Using Smartphone Data as a Diagnostic Marker for Alzheimer's Disease.

Start date: July 27, 2023
Phase: N/A
Study type: Interventional

This study will compare smartphone usage data between three groups of patients diagnosed with either a memory complaint, mild cognitive decline, or Alzheimer's disease.

NCT ID: NCT05668598 Recruiting - Clinical trials for Neurocognitive Disorders

Creation of an Ecological Tool Assessing Episodic Memory in Geriatrics

ECOTESTGER
Start date: March 8, 2023
Phase: N/A
Study type: Interventional

In this study the participants can be recruited via scheduled consultation and external institutions (associations, senior club..). Neuropsychological assessment will be realize to determine presence or absence of neurodegenerative disease. Study test is ecological MAI. This test are assigned in two groups (with or without neurocognitive disorders).

NCT ID: NCT05662280 Recruiting - Working Memory Clinical Trials

NIMH K23: Modulation of Frontoparietal Dynamics in Adolescent Working Memory Deficits

Start date: December 1, 2022
Phase: N/A
Study type: Interventional

Working memory (WM) deficits are a transdiagnostic feature of adolescent psychopathology that substantially contribute to poor clinical and functional outcomes. This proposal will utilize a multimodal neuroscientific approach to investigate whether non-invasive brain stimulation can modulate the neural mechanisms underlying adolescent WM deficits. Directly in line with NIMH priorities, the researchers will identify the contributing roles of prefrontal and parietal regions in WM processes, as well as identify optimal targets and parameters for novel brain-based treatments in adolescent psychopathology. This study is funded by the NIMH-K23

NCT ID: NCT05661084 Recruiting - Alzheimer Disease Clinical Trials

Non-invasive Brain Stimulation for Cognitive and Motor Dysfunction in Dementia

ACDCStim
Start date: January 24, 2023
Phase: N/A
Study type: Interventional

This project aims to examine the efficacy of remote, caregiver-led tES/brain stimulation intervention targeted to improve memory, mobility, and executive functioning among older adults with mild cognitive impairment or mild dementia.

NCT ID: NCT05594017 Recruiting - Epilepsy Clinical Trials

Pharmacological Modulation of Brain Oscillations in Memory Processing

Start date: August 1, 2019
Phase: Early Phase 1
Study type: Interventional

The goal of this study is to learn about the effects of scopolamine (an anticholinergic drug) on areas of the brain involved in memory, and changes it may have on brain activity. The investigators will do this by testing epileptic patients who are already undergoing intracranial surgery for seizure monitoring, and measuring the activity from the brain areas being assessed. The main questions it aims to answer are 1) whether scopolamine changes memory activity solely at encoding (the time when the person perceives and determines to remember an item or event) as has previously been found, or if it also can selectively impact retrieval (when the item or event which has been processed is recalled or remembered), and 2) what the nature of the brain activity changes is. Participants will complete two treatment arms. One of these will be with the drug, and the other will be with a saline solution, so that the participants are unaware which session the actual drug has been received. Patients will complete a verbal and/or spatial task each of the two days. An anesthesiologist will administer either the drug or the saline at a critical point which addresses both of the research questions. Researchers will compare the brain activity between the two treatment arms to determine what brain activity changes, and at what time point during memory formation.

NCT ID: NCT05569902 Completed - Memory Deficits Clinical Trials

tACS Improves Memory in Elders With Subjective Memory Complaints

Start date: October 1, 2021
Phase: N/A
Study type: Interventional

Subjective memory complaints (SMC), the main cognitive component of which is event memory, is a predictor of Alzheimer's disease in elderly people. The purpose of this study was to investigate the effect of transcranial alternating current stimulation (tACS) with theta frequency (6 Hz) on the medial prefrontal cortex in the improvement of episodic memory in individuals with SMC in a double blind, randomized, and sham-controlled parallel study. Sixteen participants with SMC received either active or sham theta tACS on the medial prefrontal cortex (mPFC). EEG was recorded and Rey Auditory Verbal Learning Test (RAVLT) was administered. The aim of the current study was to see if theta tACS over the mPFC can improve event memory in individuals with SMC and thus can be considered a potential therapeutic intervention for this population or not.

NCT ID: NCT05550727 Active, not recruiting - Alzheimer Disease Clinical Trials

The PorchLight Project

Start date: September 23, 2022
Phase: N/A
Study type: Interventional

The proposed project is a fully embedded pragmatic trial (R01), following an R61 pilot collaboration with Lutheran Social Service of Minnesota (LSS-MN). For this project: a) the training program for Senior Companions that was developed in the R61 Phase will now be delivered as part of a routine onboarding process provided by LSS-MN to all senior support volunteers in half of their program regions across Minnesota; LSS-MN will offer the PorchLight Project program to all regions and volunteers in the state during the final months of the proposed NIA project, consistent with quality improvement approaches; and b) LSS-MN will administer regular surveys to volunteers, clients, and their proxies (e.g., family caregivers) as part of ongoing tracking and quality improvement efforts. The University of Minnesota investigators will not collect data nor administer training, as these activities will be fully integrated into the workflow of LSS-MN. UNIVERSITY OF MINNESOTA INVOLVEMENT: The University of Minnesota and collaborating investigators outside of LSS-MN will only 1) assist in survey item selection, 2) randomize the LSS-MN regions for the initial phases of the real-world trial for evaluation purposes, 3) analyze the de-identified data shared by LSS-MN, and 4) disseminate the project results in scientific, practice, and policy outlets/contexts.

NCT ID: NCT05523115 Completed - Anxiety Clinical Trials

An Exploratory Investigation of a Supplement to Promote Cognitive Health Benefits

Start date: June 15, 2022
Phase: N/A
Study type: Interventional

The Smart Supplement has 20 vitamins and minerals that have strong track records of demonstrating positive health effects, both physiologically and cognitively. This twelve-week trial will examine the effectiveness and efficacy of Heights Smart Supplement on both biomarkers and subjective experiences from participants.